Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Exelon offers comparatively visible regulated-utility growth: management reaffirmed 2026 adjusted operating EPS guidance of $2.81-$2.91, expects annualized EPS growth near the upper end of 5%-7% through 2029, and projects 7.9% rate-base growth supported by a $41.7 billion four-year capital program. Reliability remains strong, and 86% of planned 2026 debt financing had been executed by the second-quarter report. Offsetting these merits are regulatory execution risk, affordability pressure, substantial ongoing financing needs, and exposure to cyber, physical-security, extreme-weather, supply-chain, and capital-market disruptions.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets17 analysts · as of 18 Aug 2026
Low · most bearish analyst$41.00
Mean target$49.18
High · most bullish analyst$58.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$41.0023%

Material rate-case disallowances, worsening customer-affordability pressure, higher financing costs, or weaker reliability delay capital recovery and push earnings below guidance. Physical-security, cybersecurity, extreme-weather, supply-chain, or third-party generation-adequacy disruptions could compound the downside.

Base CaseCentral scenario
$49.1858%
Matches the consensus mean

Exelon delivers 2026 adjusted operating EPS within the reaffirmed $2.81-$2.91 range, completes its financing plan, and receives broadly constructive but not uniformly full regulatory recovery. Rate-base expansion supports durable mid-single-digit earnings growth, while affordability initiatives and customer protections help preserve regulatory relationships.

Bull CaseUpside scenario
$58.0019%

Regulatory outcomes support planned investment, all utilities sustain top-quartile reliability, financing is completed without material cost escalation, and incremental transmission demand is protected by enforceable large-load agreements. These conditions would support earnings growth near the top of management's 5%-7% range through 2029.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Management reaffirmed 2026 adjusted operating EPS guidance of $2.81-$2.91 and annualized operating-EPS growth near the upper end of 5%-7% through 2029.
  • A $41.7 billion four-year capital plan is expected to produce 7.9% rate-base growth, while every utility is projected to maintain top-quartile reliability.
  • Exelon had executed approximately 86% of planned 2026 debt financings and reported more than $1 billion of customer protections under transmission security agreements for large new loads.
Sign in / Sign up to read more
Key Investment Risks
  • Earnings and capital recovery depend heavily on outcomes and timing across multiple state and federal regulatory proceedings, including BGE's pending Maryland electric-distribution case.
  • Higher energy-supply costs and customer-affordability pressure may increase political and regulatory resistance even when supply costs are outside the utilities' direct control.
  • The investment program remains exposed to capital-market instability, credit-rating pressure, supply-chain inflation, cybersecurity, physical-security events, extreme weather, and third-party generation shortfalls.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.